Core Insights - Yongji Co., a leading tobacco label company in Guizhou, has faced significant challenges in its capital operations, including two failed capital increases and two unsuccessful cross-industry acquisitions within two years [1][4]. Financial Performance - In the first half of 2025, the company achieved a revenue of 428 million yuan, representing a year-on-year increase of 11.91%, but the net profit attributable to shareholders dropped to 56.61 million yuan, a decrease of 27.67% [2]. - The company's net profit after deducting non-recurring gains and losses fell by 41.12% year-on-year, indicating a more severe decline in the profitability of its core business [3]. Strategic Challenges - Yongji Co. has been actively seeking transformation due to sluggish growth in its main business. In 2020, the company invested in the Australian controlled drug (medical cannabis) sector to cultivate a second main business [3]. - The company attempted to enter the semiconductor field by acquiring a 51% stake in Shanghai Aiyuan Semiconductor for 107 million yuan in 2021, but this investment has underperformed, with cumulative losses exceeding 34 million yuan from 2022 to 2024 [3]. - In August 2025, the company planned to acquire the chip company Tenafei, but the plan was terminated just two weeks later, highlighting the difficulties traditional companies face during transformation [4].
永吉股份定增屡战屡败 主业不振跨界梦难圆